Eva Yin, Partner, Wilson Sonsini
Eva Yin, Ph.D., M.P.H., is a partner in Wilson Sonsini’s FDA regulatory, healthcare, and consumer products practice. Her practice includes conducting FDA and healthcare regulatory due diligence for corporate transactions; providing legal counsel to manufacturers regarding FDA approval/clearance for various products—including medical devices, mobile apps, and drugs, FDA compliance, regulation of promotional materials and labeling, and manufacturer compliance under federal and state healthcare laws, e.g., the federal Anti-Kickback Statute (AKS), False Claims Act (FCA), Sunshine Act, state licensing laws, corporate practice of medicine, etc.; reviewing contracts and compliance policies for manufacturers; and providing legal analysis and risk assessment of business models and fee arrangements involving patient assistance programs, healthcare professionals, or hospitals/clinics under federal and state healthcare laws and regulations. Eva’s prior experience also includes patent counseling and patent prosecution for various life sciences and biotechnology companies, freedom-to-operate analysis, non-infringement and invalidity analyses, and legal research for matters involving proceedings before the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office. Before joining Wilson Sonsini, Eva worked as an associate in the healthcare group of Sidley Austin LLP in San Francisco, where she advised pharmaceutical and medical device manufacturers on healthcare regulatory compliance, risks under the AKS, risks of off-label marketing, and Medicare coverage and reimbursement matters, as well as represented pharmaceutical and medical device manufacturers in government investigations. Eva has earned several accolades, including recognition on the 2024 “Lawdragon 500 X – The Next Generation” list, the 2023 Asian Leadership Awards from Profiles in Diversity Journal, and as a top author for life sciences by JD Supra’s “2023 Readers’ Choice Awards.” Eva holds a J.D. from the University of California College of the Law, an M.P.H. from Johns Hopkins Bloomberg School of Public Health, and a Ph.D. in Molecular Biophysics and Biochemistry from Yale University. She also earned her B.S. in Chemistry and Biology from Emory University. She is an active member of the American Health Law Association and the Food and Drug Law Institute. She is admitted to the State Bars of California and Washington, and the U.S. Patent and Trademark Office. Eva’s significant contributions to the legal field also extend to her numerous publications and speaking engagements, shedding light on topics such as healthcare regulatory landscapes, medical product and service regulatory initiatives, and the impact of regulatory laws on different business models.
